Tadej Battelino

Has grant

University Children's Hospital
Country flagSlovenia

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Etiology, early detection and treatment of diseases in childhood and adolescence

Open Date:

Close Date:

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Type 1 diabetes (T1D) is one of the most common chronic diseases of the endocrine system, associated with several life-threatening comorbidities. While the etiopathogenesis of T1D remains elusive, a combination of genetic susceptibility and environmental factors, such as microbial infections, are thought to be involved in the development of the disease. The prime model for studying the genetic component of T1D predisposition encompasses polymorphisms within the HLA (human leukocyte antigen) region responsible for the specificity of antigen presentation to lymphocytes. Apart from polymorphisms, genomic reorganization caused by repeat elements and endogenous viral elements (EVEs) might be involved in T1D predisposition. Such elements are human endogenous retroviruses (HERVs) and non-long terminal repeat (non-LTR) retrotransposons, including long and short interspersed nuclear elements (LINEs and SINEs). In line with their parasitic origin and selfish behaviour, retrotransposon-imposed gene regulation is a major source of genetic variation and instability in the human genome, and may represent the missing link between genetic susceptibility and environmental factors long thought to contribute to T1D onset. Autoreactive immune cell subtypes with differentially expressed retrotransposons can be identified with single-cell transcriptomics, and personalized assembled genomes can be constructed, which can then serve as a reference for predicting retrotransposon integration/restriction sites. Here we review what is known to date about retrotransposons, we discuss the involvement of viruses and retrotransposons in T1D predisposition, and finally we consider challenges in retrotransposons analysis methods.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (13)

Lars Sävendahl

Karolinska Institutet

SWEDEN
View details

Simon Heller

Professor of Clinical Diabetes

University of Sheffield

UNITED KINGDOM
View details

Eric Renard

-

FRANCE
View details

Jernej Kovač

-

SLOVENIA
View details

Urh Groselj

-

SLOVENIA
View details

Tine Tesovnik

-

SLOVENIA
View details

Ivana Rabbone

-

ITALY
View details

Stefan Kölker

-

GERMANY
View details

Klemen Dovč

-

SLOVENIA
View details

Linda A. diMeglio

-

UNITED STATES
View details

Viktor Kožich

Professor of Medical Genetics

Charles University

CZECH REPUBLIC
View details

Thomas R. Pieber

Medical University of Graz

AUSTRIA
View details

Roberto Franceschi

Provincia autonoma di Trento Azienda Provinciale per i Servizi Sanitari

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.